
Orthofix Medical OFIX
$ 11.57
0.3%
Annual report 2025
added 02-24-2026
Orthofix Medical Accounts Payables 2011-2026 | OFIX
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.4 M | 48.8 M | 58.4 M | 27.6 M | 26.5 M | 23.1 M | - | 18 M | 18.1 M | 14.4 M | 16.4 M | 13.2 M | 20.7 M | 21.8 M | 20.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.4 M | 13.2 M | 27.5 M |
Quarterly Accounts Payables Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.5 M | 45.1 M | 45.2 M | 48.8 M | 47.1 M | 50.4 M | 57.1 M | 58.4 M | 53.3 M | 51.3 M | 45.9 M | 27.6 M | 28 M | - | 27.4 M | 26.5 M | 19.4 M | 20.1 M | 21.1 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 18 M | 18 M | 18 M | 18 M | 18.1 M | 13.4 M | 18.1 M | 18.1 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 20.7 M | 20.7 M | 20.7 M | 20.7 M | 22.6 M | 22.6 M | 22.6 M | 21.8 M | 18.2 M | 16.5 M | 16.5 M | 20.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 58.4 M | 13.2 M | 25.1 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Abbott Laboratories
ABT
|
4.24 B | $ 102.58 | -0.28 % | $ 179 B | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 12.17 | 1.16 % | $ 1.64 B | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
Align Technology
ALGN
|
109 M | $ 172.16 | 0.91 % | $ 12.9 B | ||
|
Apyx Medical Corporation
APYX
|
3.06 M | $ 3.88 | 5.43 % | $ 159 M | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 10.93 | 0.92 % | $ 1.64 B | ||
|
AxoGen
AXGN
|
2.89 M | $ 33.66 | -2.26 % | $ 1.55 B | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.1 | -0.36 % | $ 868 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 36.75 | -0.03 % | $ 5.48 K | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 63.21 | 0.62 % | $ 93.6 B | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.53 | 1.71 % | $ 270 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 34.78 | -0.03 % | $ 1.08 B | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.6 | 2.92 % | $ 37.3 M | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.72 | 0.88 % | $ 348 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.56 | 5.0 % | $ 133 M | ||
|
Electromed
ELMD
|
2.67 M | $ 23.59 | 1.29 % | $ 199 M | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 81.57 | 0.64 % | $ 47.7 B | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.56 | -0.16 % | $ 122 M | ||
|
NanoVibronix
NAOV
|
47 K | - | - | $ 1.08 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 87.65 | -0.31 % | $ 11.9 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 1.97 | 5.65 % | $ 1.2 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 9.4 | -1.36 % | $ 724 M | ||
|
Inogen
INGN
|
20.3 M | $ 6.46 | 4.03 % | $ 172 M | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 56.86 | 3.4 % | $ 1.67 B | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.01 | 3.09 % | $ 17.1 M |